Skip to main content
. 2021 Aug 15;13(8):2792. doi: 10.3390/nu13082792

Figure 2.

Figure 2

Figure 2

Effects of cisplatin and LCs supplementation on inflammation responses in kidney tissues. (A) Serum MPO. (B) Kidney MPO. (C) IL-10. Results are shown as mean ± SEM (n = 7 per group). * p < 0.05 compared with the control group; # p < 0.05 compared with the cisplatin group.